← Back to Search

Behavioral Intervention

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

N/A
Waitlist Available
Led By Alice Ye, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Provision of signed and dated electronic informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.

Who is the study for?
This trial is for individuals experiencing peripheral neuropathy, which often causes numbness, tingling, or pain in the limbs. Participants should be interested in a personalized approach to manage their condition by setting and working towards their own health goals.
What is being tested?
The intervention being studied is Goal Attainment Scaling (GAS), a method that helps patients set personal health-related goals and track their progress over time. The study focuses on shifting from traditional disease treatment to individualized patient care.
What are the potential side effects?
Since GAS is a behavioral technique rather than a medication, it does not have physical side effects. However, participants may experience emotional or psychological responses as they engage with the goal-setting process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety and Adverse Events (AEs)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: No Goal EncouragementExperimental Treatment1 Intervention
Eligible participants will be identified using electronic health record
Group II: Goal EncouragementExperimental Treatment1 Intervention
Eligible participants will be identified using electronic health record

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,072 Previous Clinical Trials
1,803,181 Total Patients Enrolled
Alice Ye, MDPrincipal InvestigatorM.D. Anderson Cancer Center
~30 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top